MICHELLE BOONE: Open Payments
NPI 1215310784 · NASHVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 13 payments from 9 companies in 2025. Trend: 2023 $33 · 2024 $88 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 1 | $111 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| ABBVIE INC. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Averitas Pharma Inc. | 1 | $14 |
Products named: Korlym, REXULTI, VRAYLAR, CAPLYTA, Auvelity, HETLIOZ, AUSTEDO XR, TRINTELLIX.
Industry payments across AR — which companies pay providers there.
